Pfizer seeks U.S approval for third shot COVID booster

Pfizer on Wednesday said a booster dose of its two-shot COVID-19 vaccine spurs a more than threefold increase in antibodies against the coronavirus, as the company seeks US regulatory approval for a third injection. According to Reuters, the drug-maker and its German partner BioNTech SE aim to complete the